Aging; Cognitive decline; Alzheimer; Neuropigenetics; Neuropharmacology

Christian Griñán Ferré

This constitutes a new research line initiated by Dr. Christian Griñán-Ferré, by using C. elegans, as well as several mice models of neurodegeneration. The research interest is the development of new chemical entities based on epigenetics to ameliorate and prevent neurodegenerative diseases, including brain rare disorders. He is also interested in the implications of the transgenerational epigenetic inheritance in the cognitive decline risk for the next generation. The advanced research projects included G9a/GLP inhibitors....